Loading…
Effectiveness of pharmacist intervention model for chronic kidney disease patients; a prospective comparative study
Background Chronic Kidney Disease (CKD) is a global health concern with profound risk of cardiovascular disease, end stage renal failure and early mortality. Pharmacists’ interventions during chronic disease management have been promising. However, evidence of pharmacist`s involvement in chronic kid...
Saved in:
Published in: | International journal of clinical pharmacy 2020-04, Vol.42 (2), p.625-634 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
Chronic Kidney Disease (CKD) is a global health concern with profound risk of cardiovascular disease, end stage renal failure and early mortality. Pharmacists’ interventions during chronic disease management have been promising. However, evidence of pharmacist`s involvement in chronic kidney dosease is limited, particularly in developing countries.
Objective
To implement and evaluate the impact of pharmacist led intervention among pre-dialysis CKD patients.
Setting
Nephrology outpatient department of tertiary healthcare hospital.
Methods
Patients with chronic kidney disease from stage 2 to 4 attending hospital between October to December 2018 were enrolled in a multi-arm pre-post prospective study. Pharmacist interventional model consisted of disease education, dietary recommendations, counseling to improve medication adherence along with telephonic follow-up. Interventional group received pharmacist interventional model; whereas control group only received the usual care. The impact of pharmacist`s involvements were evaluated by observing the improvements in knowledge and adherence scores, physiological profile and body composition analysis assessed by body composition monitor (BF-508
®
) at the end of follow-up of 3 months. Both intervention and control groups were compared by appropriate statistical techniques.
Main outcome measure
Knowledge and adherence scores, physiological profile and body composition analysis
Results
Total 120 patients (60 in each group) completed the study. Baseline variables were comparable between the two groups. Pharmacist interventional model causes significant improvement in knowledge score upon follow up between intervention and control groups (19.10 ± 3.65 versus 17.57 ± 3.55,
p
= 0.022). Likewise, Medication adherence score of intervention group significantly improved as compared to control group (
p
|
---|---|
ISSN: | 2210-7703 2210-7711 |
DOI: | 10.1007/s11096-020-00982-w |